Resultats de la cerca - Chelsee Greer
- Mostrar 1 - 1 resultats de 1
-
1
Pediatric relapsed/refractory ALK+ anaplastic large cell lymphoma treatment and outcomes in the targeted drug era per Lianna J. Marks, Victor Ritter, Jennifer E. Agrusa, Kala Y. Kamdar, Julie Rivers, Rebecca Gardner, Matthew J. Ehrhardt, Kaitlin J. Devine, Charles Phillips, Anne F. Reilly, Keith J. August, Joanna Weinstein, Prakash Satwani, Christopher J. Forlenza, Christine M. Smith, Chelsee Greer, Zeinab Afify, Carol Lin, Jennifer A. Belsky, Hilda Ding, David J. Hoogstra, Keri Toner, Michael P. Link, Liora M. Schultz, Eric Lowe, Catherine Aftandilian
Publicat 2025Artigo
Eines de cerca:
Matèries relacionades
ALK inhibitor
Anaplastic large-cell lymphoma
Anaplastic lymphoma kinase
Astrobiology
Brentuximab vedotin
CD30
Cancer
Chemotherapy
Chemotherapy regimen
Crizotinib
Gastroenterology
Hematopoietic stem cell transplantation
Internal medicine
Lymphoma
Malignant pleural effusion
Medicine
Oncology
Physics
Pleural effusion
Refractory (planetary science)
Regimen
Retrospective cohort study
Targeted therapy
Transplantation